Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...
The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.
Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.
Interesting Engineering on MSN11d
US firm follows unique pulsed magnetic concept to achieve fusion for limitless energyBased in Fremont, Pacific Fusion plans to use pulsed magnetic concept to achieve fusion energy. Pulsed magnetic fusion uses ...
Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
As Timothy considered his surgical options, he found out about a revolutionary procedure called pulsed-field ablation. ALSO| ...
Optimized to drive a wide range of magnetron models with peak RF power of up to 2 MW, the M060 is engineered for adaptability across diverse environments. The modulator leverages cutting-edge ...
Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...
Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...
which will combine to provide visualization for cardiac ablation procedures with the FARAPULSE Pulsed Field Ablation (PFA) System. Boston Scientific noted that the technologies are compatible ...
The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback